Opinicus Capital, Inc. Novo Nordisk A S Transaction History

Opinicus Capital, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 08, 2025	SELL	$58.08 - $81.05 $33,047 - $46,117	-569 Reduced 12.39%	4,024 $278 Million
Q1 2025 Apr 16, 2025	BUY	$69.3 - $90.95 $73,042 - $95,861	1,054 Added 29.78%	4,593 $319 Million
Q4 2024 Jan 28, 2025	SELL	$85.0 - $120.04 $38,080 - $53,777	-448 Reduced 11.24%	3,539 $304 Million
Q3 2024 Nov 04, 2024	SELL	$119.07 - $145.42 $98,232 - $119,971	-825 Reduced 17.14%	3,987 $475 Million
Q2 2024 Jul 22, 2024	SELL	$122.71 - $146.91 $736 - $881	-6 Reduced 0.12%	4,812 $687 Million

Q1 2024 Apr 16, 2024	BUY	$102.11 - $135.92 $491,965 - $654,862	4,818 New	4,818 $619 Million

1,680

304M

25.9M

43.8M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $109B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Opinicus Capital, Inc., based on Form 13F filings with the SEC.

Stay updated on Opinicus Capital, Inc. with notifications on news.